BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 14766317)

  • 1. Mitochondrial dysfunction as a cause of optic neuropathies.
    Carelli V; Ross-Cisneros FN; Sadun AA
    Prog Retin Eye Res; 2004 Jan; 23(1):53-89. PubMed ID: 14766317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial optic neuropathies: how two genomes may kill the same cell type?
    Carelli V; La Morgia C; Iommarini L; Carroccia R; Mattiazzi M; Sangiorgi S; Farne' S; Maresca A; Foscarini B; Lanzi L; Amadori M; Bellan M; Valentino ML
    Biosci Rep; 2007 Jun; 27(1-3):173-84. PubMed ID: 17479363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial optic neuropathies.
    Carelli V; La Morgia C; Yu-Wai-Man P
    Handb Clin Neurol; 2023; 194():23-42. PubMed ID: 36813316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
    Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
    Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.
    Yu-Wai-Man P; Griffiths PG; Chinnery PF
    Prog Retin Eye Res; 2011 Mar; 30(2):81-114. PubMed ID: 21112411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
    Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
    Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.
    Carelli V; La Morgia C; Valentino ML; Barboni P; Ross-Cisneros FN; Sadun AA
    Biochim Biophys Acta; 2009 May; 1787(5):518-28. PubMed ID: 19268652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited mitochondrial optic neuropathies.
    Yu-Wai-Man P; Griffiths PG; Hudson G; Chinnery PF
    J Med Genet; 2009 Mar; 46(3):145-58. PubMed ID: 19001017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy.
    Asanad S; Tian JJ; Frousiakis S; Jiang JP; Kogachi K; Felix CM; Fatemeh D; Irvine AG; Ter-Zakarian A; Falavarjani KG; Barboni P; Karanjia R; Sadun AA
    Curr Eye Res; 2019 Jun; 44(6):638-644. PubMed ID: 30649972
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary optic neuropathies share a common mitochondrial coupling defect.
    Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
    Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options.
    Carelli V; La Morgia C; Sadun AA
    Curr Opin Neurol; 2013 Feb; 26(1):52-8. PubMed ID: 23302804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic basis of primary inherited optic neuropathies.
    Votruba M
    Eye (Lond); 2004 Nov; 18(11):1126-32. PubMed ID: 15534598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial transport mediates survival of retinal ganglion cells in affected LHON patients.
    Yang TC; Yarmishyn AA; Yang YP; Lu PC; Chou SJ; Wang ML; Lin TC; Hwang DK; Chou YB; Chen SJ; Yu WK; Wang AG; Hsu CC; Chiou SH
    Hum Mol Genet; 2020 Jun; 29(9):1454-1464. PubMed ID: 32277753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary optic atrophies].
    Scherer C; Procaccio V; Ferre M; Guillet V; Reynier P; Amati-Bonneau P; Dubas F; Bonneau D; Verny C
    Rev Neurol (Paris); 2010 Dec; 166(12):959-65. PubMed ID: 21056443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic neuropathies: the tip of the neurodegeneration iceberg.
    Carelli V; La Morgia C; Ross-Cisneros FN; Sadun AA
    Hum Mol Genet; 2017 Oct; 26(R2):R139-R150. PubMed ID: 28977448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete penetrance in mitochondrial optic neuropathies.
    Caporali L; Maresca A; Capristo M; Del Dotto V; Tagliavini F; Valentino ML; La Morgia C; Carelli V
    Mitochondrion; 2017 Sep; 36():130-137. PubMed ID: 28716668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LHON and other optic nerve atrophies: the mitochondrial connection.
    Howell N
    Dev Ophthalmol; 2003; 37():94-108. PubMed ID: 12876832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neurodegenerative perspective on mitochondrial optic neuropathies.
    Yu-Wai-Man P; Votruba M; Burté F; La Morgia C; Barboni P; Carelli V
    Acta Neuropathol; 2016 Dec; 132(6):789-806. PubMed ID: 27696015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
    Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
    Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.